Literature DB >> 957599

Renin, aldosterone and arterial pressure responses to acute beta-adrenergic receptor blockage in hypertensive patients.

K O Stumpe, R Kolloch, W Gramann, H Vetter, C Ressel, M Higuchi, F Krück.   

Abstract

The effect of acute (intravenous) beta-adrenergic blockade with propranolol or pindolol on arterial pressure (BP), plasma renin activity (PRA), and plasma concentration of aldosterone (PA) was evaluated in 20 essential hypertensive men. BP, PRA and PA were determined during continuous recumbency over-night (8 p.m. to 6 a.m.) every 30 min. Two groups of patients were observed. Patients of group 1 exhibited a characteristic day-night rhythm of PRA with low values before midnight and large increases early in the morning. Conversely, no rhythm and very low PRA values were observed in patients of group II. BP was higher in group II than in group I. In group I following intravenous propranolol or pindolol, BP fell within minutes and levels as well as rhythms of PRA were converted to those of group II without treatment. In group II day-night profiles of PRA and BP remained unchanged. Rhythm and concentration of PA in the two groups were not influenced by either drug. In 4 patients of group I infusion of angiotensin II inhibitor did not lower BP. The observations suggest that in the two groups dissimilarities in rhythms of PRA as well as in BP responses to beta-blockade may reflect differences in neuro-adrenergic tone.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 957599     DOI: 10.1007/BF01614294

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  31 in total

1.  Diurnal variation of plasma aldosterone, cortisol and renin activity in supine man.

Authors:  F H Katz; P Romfh; J A Smith
Journal:  J Clin Endocrinol Metab       Date:  1975-01       Impact factor: 5.958

2.  Neurogenic factors in human hypertension: mechanism or myth?

Authors:  V DeQuattro; Y Miura
Journal:  Am J Med       Date:  1973-09       Impact factor: 4.965

3.  Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.

Authors:  J H Laragh
Journal:  Am J Med       Date:  1973-09       Impact factor: 4.965

4.  Beta-adrenergic blocking therapy in hypertension: selection of patients.

Authors:  E D Frohlich; R C Tarazi; H P Dustan
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1970-12

5.  A potent beta-adrenoreceptor blocking drug: 4-(2-hydroxy-3-isopropylaminopropoxy)indole.

Authors:  G E Moore; S R O'Donnell
Journal:  J Pharm Pharmacol       Date:  1970-03       Impact factor: 3.765

6.  The effect of chronic adrenergic receptor blockade on plasma renin activity in man.

Authors:  A M Michelakis; R G McAllister
Journal:  J Clin Endocrinol Metab       Date:  1972-02       Impact factor: 5.958

7.  Adrenergic receptor mechanisms and renin secretion.

Authors:  R Vandongen
Journal:  Aust N Z J Med       Date:  1974-06

8.  Plasma aldosterone-renin interrelationships in various forms of essential hypertension. Studies using a rapid assay of plasma aldosterone.

Authors:  F R Bühler; J H Laragh; J E Sealey; H R Brunner
Journal:  Am J Cardiol       Date:  1973-09-20       Impact factor: 2.778

9.  On the mechanism of suppressed plasma-renin activity during beta-adrenergic blockade with propranolol.

Authors:  E L Bravo; R C Tarazi; H P Dustan
Journal:  J Lab Clin Med       Date:  1974-01

10.  Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity.

Authors:  R D Collins; M H Weinberger; A J Dowdy; G W Nokes; C M Gonzales; J A Luetscher
Journal:  J Clin Invest       Date:  1970-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.